Tolterodine does not affect the human in vivo metabolism of the probe drugs caffeine, debrisoquine and omeprazole.
about
How useful is the "cocktail approach" for evaluating human hepatic drug metabolizing capacity using cytochrome P450 phenotyping probes in vivo?Interferon-beta treatment in patients with multiple sclerosis does not alter CYP2C19 or CYP2D6 activityEffect of the proton pump inhibitor omeprazole on the pharmacokinetics of extended-release formulations of oxybutynin and tolterodine.
P2860
Tolterodine does not affect the human in vivo metabolism of the probe drugs caffeine, debrisoquine and omeprazole.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Tolterodine does not affect th ...... , debrisoquine and omeprazole.
@en
type
label
Tolterodine does not affect th ...... , debrisoquine and omeprazole.
@en
prefLabel
Tolterodine does not affect th ...... , debrisoquine and omeprazole.
@en
P2093
P2860
P1476
Tolterodine does not affect th ...... , debrisoquine and omeprazole.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2125.1999.00865.X
P407
P577
1999-02-01T00:00:00Z